A proliferation‐inducing ligand–mediated anti‐inflammatory response of astrocytes in multiple sclerosis - Archive ouverte HAL Access content directly
Journal Articles Annals of Neurology Year : 2019

A proliferation‐inducing ligand–mediated anti‐inflammatory response of astrocytes in multiple sclerosis

(1) , (2) , (3) , (1) , (1) , (4) , (4) , (3) , (3) , (5) , (6) , (7) , (7) , (7) , (8) , (8) , (9) , (10) , (11) , (11) , (1) , (12) , (13) , (3) , (2, 14) , (1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Hugues Lortat-Jacob

Abstract

OBJECTIVE: The two related tumor necrosis factor members a proliferation-inducing ligand (APRIL) and B-cell activation factor (BAFF) are currently targeted in autoimmune diseases as B-cell regulators. In multiple sclerosis (MS), combined APRIL/BAFF blockade led to unexpected exacerbated inflammation in the central nervous system (CNS) of patients. Here, we investigate the role of the APRIL/BAFF axis in the CNS. METHODS: APRIL expression was analyzed in MS lesions by immunohistochemistry. The in vivo role of APRIL was assessed in the murine MS model, experimental autoimmune encephalitis (EAE). Functional in vitro studies were performed with human and mouse astrocytes. RESULTS: APRIL was expressed in lesions from EAE. In its absence, the disease was worst. Lesions from MS patients also showed APRIL expression upon infiltration of macrophages. Notably, all the APRIL secreted by these macrophages specifically targeted astrocytes. The upregulation of chondroitin sulfate proteoglycan, sometimes bearing chondroitin sulfate of type E sugar moieties, binding APRIL, in reactive astrocytes explained the latter selectivity. Astrocytes responded to APRIL by producing a sufficient amount of IL-10 to dampen antigen-specific T-cell proliferation and pathogenic cytokine secretion. Finally, an intraspinal delivery of recombinant APRIL before disease onset, shortly reduced EAE symptoms. Repeated intravenous injections of recombinant APRIL before and even at disease onset also had an effect. INTERPRETATION: Our data show that APRIL mediates an anti-inflammatory response from astrocytes in MS lesions. This protective activity is not shared with BAFF. ANN NEUROL 2019;85:406-420. © 2019 American Neurological Association.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02332844 , version 1 (25-10-2019)

Identifiers

Cite

Laurie Baert, Mahdia Benkhoucha, Natalia Popa, Mashal C Ahmed, Benoit Manfroi, et al.. A proliferation‐inducing ligand–mediated anti‐inflammatory response of astrocytes in multiple sclerosis. Annals of Neurology, 2019, 85 (3), pp.406-420. ⟨10.1002/ana.25415⟩. ⟨inserm-02332844⟩
361 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More